This inventor holds 3 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2000
Title: Kevin D. Shenk: Innovator in Psychotherapeutics and Neurokinin Antagonists
Introduction
Kevin D. Shenk is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of psychotherapeutics and neurokinin antagonists. With a total of 3 patents, his work has the potential to impact various medical treatments.
Latest Patents
One of his latest patents involves aryl and heteroaryl alkoxynaphthalene derivatives. These compounds are defined by specific formulas and are recognized for their utility as psychotherapeutics. They act as potent serotonin (5-HT1) agonists and antagonists. Another significant patent pertains to diazabicyclic neurokinin antagonists. This invention focuses on diazabicyclic compounds that are useful in treating inflammatory and central nervous system disorders.
Career Highlights
Kevin D. Shenk is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to explore innovative solutions in drug development and therapeutic applications.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including Harry R. Howard, Jr. and Bertrand Leo Chenard. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Kevin D. Shenk is a distinguished inventor whose work in psychotherapeutics and neurokinin antagonists showcases his commitment to advancing medical science. His contributions continue to pave the way for innovative treatments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile